Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1244 of 6351
-
Can a higher dose of upadacitinib rescue ulcerative colitis patients when standard treatment fails?
Disease control Not yet recruitingReCOUP is a multicenter clinical study designed to evaluate the efficacy of upadacitinib (Rinvoq®) in patients with ulcerative colitis whose disease has become active again despite maintenance treatment with upadacitinib 30 mg. This study involves adult patients aged 18 to 64 ye…
Phase 4 • Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New cream aims to soothe butterfly skin in Late-Stage trial
Symptom relief Not yet recruitingThe objective is to characterize the continued safety of SD-101 cream containing 6% allantoin in the treatment of the skin in patients with Simplex, Recessive Dystrophic, or JEB-nH EB.
Phase 3 • Sponsor: Paradigm Therapeutics • Aim: Symptom relief
Last updated Sep 10, 2026 04:00 UTC
-
New gene shot could regrow knee cartilage and ease arthritis pain
Disease control CancelledThe purpose of this study is to determine the safety, tolerability, and activity of ICM-203, a recombinant adeno-associated viral (AAV) vector that expresses a therapeutic gene that promotes cartilage formation, reduces joint inflammation and pain, as well as improves joint physi…
Phase 1/2 • Sponsor: ICM Co. Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a new nerve block beat the standard for back surgery pain?
Symptom relief Not yet recruitingThis randomized clinical trial aims to evaluate and compare the analgesic efficacy and functional outcomes of the quadro-iliac plane block (QIPB) and the erector spinae plane block (ESPB) in patients undergoing lumbar stabilization surgery. The primary outcome is the Numeric Rati…
Sponsor: Antalya City Hospital • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
Could red light help breast cancer survivors regrow hair after chemo?
Symptom relief Not yet recruitingThis phase II trial compares the safety and effectiveness of topical minoxidil alone to topical minoxidil in combination with low-level red-light therapy for improving chemotherapy-induced hair loss or thinning (alopecia). Minoxidil has been approved by the Food and Drug Administ…
Phase 2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Gut check: could your microbiome predict cancer treatment success?
Knowledge-focused Not yet recruitingCAPTIVATE is a multi-center translational and observational trial, that aims to investigate the impact of the gut microbiome on treatment outcomes in women with untreated, stage I-III Triple Negative undergoing neoadjuvant treatment with and without immune checkpoint inhibitors. …
Sponsor: Barts & The London NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
One injection after neck surgery: a new test for better scar healing
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn whether a single polynucleotide injection can improve scar quality after thyroid or parathyroid surgery in adults. It will also assess the safety of the injection. The main questions this study aims to answer are the following: Does a…
Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
A gentler catheter may cut infection risk for women in hospitals
Disease control Not yet recruitingUrinary catheterization is commonly used in hospitalized patients for the management of urinary incontinence, immobilization, and monitoring of urinary output. However, indwelling urinary catheters (IUCs) are associated with clinically significant risks, including catheter-associ…
Sponsor: Becton, Dickinson and Company • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Blood tests may guide breast cancer treatment before surgery
Knowledge-focused Not yet recruitingTo learn whether certain blood and imaging tests can show which people with early-stage TNBC may already have had a complete response to chemotherapy before they go to surgery.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
New combo aims to shield bone marrow in tough breast cancer
Disease control Not yet recruitingTriple negative breast cancer (TNBC) has attracted much attention due to its young age of onset, high aggressiveness, lack of clear therapeutic targets and poor clinical prognosis.Eribulin is a novel non-taxane anti-microtubule inhibitor with unique microtubule and non-microtubul…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Video game rehab at home: a new way to heal the brain after injury?
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the effectiveness of a home-based cognitive-motor telerehabilitation program in individuals with traumatic brain injury (TBI) following discharge from intensive inpatient neurorehabilitation. The main questions it aims to answer are…
Sponsor: Fondazione Don Carlo Gnocchi ETS • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New Hormone-Free drug for hot flashes tested in real life
Symptom relief Not yet recruitingMenopause is a natural stage in a woman's life happening between ages 45 and 55. It is often associated with disruptive symptoms like hot flashes and sleep disturbances that can affect up to 8 out of 10 women and make daily life harder. Elinzanetant is a new, hormone free medicin…
Sponsor: Bayer • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New sleep therapy aims to boost brain health in veterans
Symptom relief Not yet recruitingInsomnia is a transdiagnostic health problem affecting the physical, cognitive, emotional, and social functioning of Veterans. Importantly, chronic insomnia may be a modifiable risk factor for progression to serious health conditions, such as mild cognitive impairment (MCI) and d…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New drug trial aims to rescue failing lungs after transplant
Disease control Not yet recruitingThis study is testing a medication called emapalumab to see if it can help people who have had a lung transplant and are experiencing a sudden drop in lung function, called acute lung allograft dysfunction (ALAD). ALAD is a serious condition that can happen after a lung transpla…
Phase 2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
How do ICUs worldwide manage breathing tubes? a massive study investigates
Knowledge-focused Not yet recruitingON TRACH is an international, multicentre, observational study with the aim of characterising the timing and practice of tracheostomy insertion, management, weaning and longer-term outcomes of these patients, in intensive care units internationally. Participating intensive care u…
Sponsor: Royal College of Surgeons, Ireland • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Veterans with opioid addiction may soon get pain relief from a web program
Symptom relief Not yet recruitingChronic pain is common in individuals with opioid use disorder (OUD) and the first-line treatment, Medication for OUD (MOUD), does not address the considerable functional impairments associated with chronic pain. Veterans with OUD and chronic pain could benefit from integrated, b…
Phase 3 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New PET tracer may reveal which bile duct cancers resist standard therapy
Diagnosis Not yet recruitingThis phase II trial studies whether \[18F\]FTT can be used with positron emission tomography (PET)/computed tomography (CT) imaging to predict treatment response in patients scheduled to receive gemcitabine, cisplatin, and durvalumab (GCD) for newly diagnosed cholangiocarcinoma. …
Phase 2 • Sponsor: University of Washington • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
New trial aims to match diabetes drugs to patients for better heart and kidney protection
Disease control Not yet recruitingBreakthrough T1D has awarded support for a joint University of Michigan-Oregon Health \& Science University Center of Excellence (CoE) to address cardio-renal complications in T1D. The overarching hypothesis of the CoE is that individuals with T1D have unique endophenotypes deter…
Phase 2 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Shock therapy without the shock? new brain zaps aim to lift mood and kill pain
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if active transcranial alternating current stimulation (tACS) and transcranial direct current stimulation (tDCS) can improve pain symptoms in patients with major depressive disorder (MDD) and chronic pain symptoms. It will also explore …
Sponsor: Shanghai Mental Health Center • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can a weekly shot bring antibody levels to safety in untreated immune deficiency?
Disease control Not yet recruitingPrimary immunodeficiency disease (or PIDD) is a group of conditions in which the immune system does not work properly. Some people with PIDD do not make enough antibodies. Antibodies are proteins that help to either protect the body from infections or fight infections. The main t…
Phase 4 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC